Tregaron’s Investment In UST Wins Deal of the Year

December 02, 2014

Tregaron Capital is pleased to announce that the M&A Advisor has selected Tregaron's investment in UST the winner of the 13th Annual M&A Deal of the Year award for transactions between $10 million and $25 million in value.  UST is a leading contract manufacturer of vitamins, dietary supplements and homeopathic drug products.  Tregaron completed its investment in UST, together with ongoing management, in late 2013.

Since the inception of the M&A Advisor Awards in 2002, the M&A Advisor has recognized the leading dealmakers, firms and transactions, celebrating the creativity, perseverance and ingenuity of this group of industry professionals.  Tregaron is honored that its recent investment in UST has been selected to receive this prestigious award.